1. A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1). (May 2018) Authors: Lindman, H.; Andersson, M.; Ahlgren, J.; Balslev, E.; Sverrisdottir, A.; Holmberg, S.B.; Bengtsson, N.O.; Jacobsen, E.H.; Jensen, A.B.; Hansen, J.; Tuxen, M.K.; Malmberg, L.; Villman, K.; Anderson, H.; Ejlertsen, B.; Bergh, J.; Blomqvist, C. Journal: European journal of cancer Issue: Volume 94(2018) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hypo- vs normofractionated radiation therapy of early stage breast cancer in the randomized DBCG HYPO trial. (February 2017) Authors: Offersen, B.V.; Nielsen, H.M.; Jacobsen, E.H.; Nielsen, M.H.; Krause, M.; Stenbygaard, L.; Mjaaland, I.; Schreiber, A.; Jensen, M.B.; Overgaard, J. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0142: Hypo- vs normofractionated radiation of early breast cancer in the randomised DBCG HYPO trial. (April 2016) Authors: Offersen, B.V.; Jacobsen, E.H.; Nielsen, M.H.; Krause, M.; Stenbygaard, L.; Mjaaland, I.; Schreiber, A.; Kasti, U.M.; Jensen, M.B.; Overgaard, J. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0334 Partial vs whole-breast irradiation for breast cancer patients in the randomized DBCG PBI trial. (August 2021) Authors: Offersen, B.; Alsner, J.; Nielsen, H.M.; Jacobsen, E.H.; Nielsen, M.H.; Stenbygaard, L.; Pedersen, A.N.; Thomsen, M.S.; Yates, E.; Berg, M.; Lorenzen, E.; Jensen, I.; Josipovic, M.; Jensen, M.; Overgaard, J. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0371: Hypo- vs normofractionated radiation of early breast cancer in the randomized DBCG HYPO trial. (November 2020) Authors: Vrou Offersen, B.; Nielsen, H.M.; Jacobsen, E.H.; Nielsen, M.H.; Krause, M.; Stenbygaard, L.; Mjaaland, I.; Schreiber, A.; Kasti, U.; Jensen, M.; Alsner, J.; Overgaard, J. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC-0596: Hypo- vs normofractionated radiation of early breast cancer in the randomized DBCG HYPO trial. (April 2018) Authors: Offersen, B.; Nielsen, H.M.; Jacobsen, E.H.; Nielsen, M.H.; Krause, M.; Stenbygaard, L.; Mjaaland, I.; Schreiber, A.; Kasti, U.M.; Jensen, M.B.; Alsner, J.; Overgaard, J. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SP-0315: Partial breast radiotherapy after breast conservation for breast cancer: early results from the randomised DBCG PBI trial. (May 2017) Authors: Offersen, B.; Nielsen, H.M.; Thomsen, M.S.; Jacobsen, E.H.; Nielsen, M.H.; Stenbygaard, L.; Pedersen, A.N.; Krause, M.; Jensen, M.B.; Overgaard, J. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗